| Revenue | 31/12/2018 | 31/12/2017 | 31/12/2016 | 31/12/2015 |
| Total revenue | - | - | - | - |
| Cost of revenue | - | - | - | - |
| Gross profit | - | - | - | - |
| Operating expenses |
| Research development | - | - | - | - |
| Selling general and administrative | 3,448.835 | 2,762.243 | 3,742.882 | 3,578.11 |
| Non-recurring | - | - | - | - |
| Others | -1,196.764 | 219.043 | 4,685.714 | 313.023 |
| Total operating expenses | 2,324.43 | 5,006.01 | 8,536.828 | 5,629.705 |
| Operating income or loss | -2,324.43 | -5,006.01 | -8,536.828 | -5,629.705 |
| Income from continuing operations |
| Total other income/expenses net | -3,669.163 | -3,402.905 | -864.436 | -675.007 |
| Earnings before interest and taxes | -2,324.43 | -5,006.01 | -8,536.828 | -5,629.705 |
| Interest expense | -4,224.698 | -2,703.317 | -1,702.878 | -689.503 |
| Income before tax | -5,993.593 | -8,408.915 | -9,401.264 | -6,304.712 |
| Income tax expense | - | - | - | - |
| Minority interest | - | - | - | - |
| Net income from continuing ops | -5,993.593 | -8,408.915 | -9,401.264 | -6,304.712 |
| Non-recurring events |
| Discontinued operations | - | - | - | - |
| Extraordinary items | - | - | - | - |
| Effect of accounting changes | - | - | - | - |
| Other items | - | - | - | - |
| Net income |
| Net income | -5,993.593 | -8,408.915 | -9,401.264 | -6,304.712 |
| Preferred stock and other adjustments | - | - | - | - |
| Net income applicable to common shares | -5,993.593 | -8,408.915 | -9,401.264 | -6,304.712 |